RetroTherapy Overview

  • Founded
  • 2004

  • Status
  • Private

  • Latest Deal Type
  • 2ndary - Private

RetroTherapy General Information


Developer of ribonucleic acid based therapeutics designed to be used for the treatment of human genetic diseases. The company develops optimal therapeutic candidates to correct the causative mutation of disease by RNA trans splicing , enabling healthcare practitioners to selectively kill cells infected with retroviruses and prevent the spread of disease.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Formerly VC-backed
Primary Industry
Other Industries
Drug Discovery
Primary Office
  • 4519 Gretna Street
  • Bethesda, MD 20814
  • United States
+1 (301) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

RetroTherapy Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Secondary Transaction - Private 01-Mar-2021 0000 Completed Generating Revenue
3. Grant 01-Jan-2007 0000 Completed Generating Revenue
2. Early Stage VC 04-Jan-2005 $50K $50K Completed Generating Revenue
1. Grant Completed Startup
To view RetroTherapy’s complete valuation and funding history, request access »

RetroTherapy Executive Team (1)

Name Title Board Seat Contact Info
Lloyd Mitchell MD Founder, Chief Executive Officer & Chief Scientific Officer
To view RetroTherapy’s complete executive team members history, request access »